Table 1 Demographics of the patients who had a cerebrospinal fluid (CSF) analysis. N = 79
From: Cerebrospinal fluid findings and hypernatremia in COVID-19 patients with altered mental status
| Â | Â | N | (%) |
|---|---|---|---|
Age (years) | < 55 | 20 | 25.3 |
≥ 55 | 59 | 74.7 | |
Sex | Male | 50 | 63.3 |
Female | 29 | 36.7 | |
Race | White | 46 | 58.2 |
Black or African American | 22 | 27.8 | |
Asian | 2 | 2.5 | |
Other | 9 | 11.4 | |
Hypernatremia | Yes | 20 (4 of them persistent) | 25.3 (20% of hypernatremia cases were ≥ 48 h) |
No | 59 | 74.7 | |
Disease severity | Mild-moderate | 37 | 46.8 |
Severe-critical | 42 | 53.2 | |
In-hospital mortality | Ex | 19 | 24.1 |
Survivor | 60 | 75.9 | |
Hospital length of stay | ≥ 1 week | 27 | 34.2 |
< 1 week | 52 | 65.8 | |
Ventilator time | ≥ 72 h | 28 | 35.4 |
< 72 h | 3 | 3.8 | |
None | 48 | 60.8 |